Following the IP bread crumb trial along with James latest interview, he mentions at the 3:00 minute mark the idea of combination therapies and the need to talk with those other drug companies. Looks and now sound likes they are widening their scoop of works for this drug. Great job and great to hear so many positive voices on this thread for a change.
- Forums
- ASX - By Stock
- KZA
- Cantrixil Study